High expressions of tumor cell genes COL5A2 and ITGAV and non-tumor cell genes SPARC and ACTA2 are both positively correlated with poor overall survival and disease-free survival in MESO cohort (Fig. 5). The gene discussed is ITGAV; the disease is neoplasm.